| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 | 
| NetGPI | no | yes: 0, no: 6 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 6 | 
| GO:0110165 | cellular anatomical entity | 1 | 6 | 
Related structures:
AlphaFold database: E9B1Y3
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.353 | 
| CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.526 | 
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.353 | 
| CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.524 | 
| CLV_PCSK_PC7_1 | 56 | 62 | PF00082 | 0.518 | 
| CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.405 | 
| DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.441 | 
| DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.614 | 
| DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.664 | 
| DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.811 | 
| LIG_14-3-3_CanoR_1 | 29 | 33 | PF00244 | 0.621 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.447 | 
| LIG_FHA_1 | 5 | 11 | PF00498 | 0.307 | 
| LIG_FHA_1 | 67 | 73 | PF00498 | 0.721 | 
| LIG_FHA_2 | 1 | 7 | PF00498 | 0.435 | 
| LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.732 | 
| LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.321 | 
| LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.615 | 
| LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.321 | 
| LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.549 | 
| LIG_SH3_3 | 101 | 107 | PF00018 | 0.634 | 
| LIG_SUMO_SIM_anti_2 | 3 | 12 | PF11976 | 0.346 | 
| LIG_SUMO_SIM_anti_2 | 73 | 78 | PF11976 | 0.577 | 
| LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.671 | 
| LIG_TYR_ITIM | 15 | 20 | PF00017 | 0.321 | 
| MOD_GSK3_1 | 50 | 57 | PF00069 | 0.724 | 
| MOD_GSK3_1 | 62 | 69 | PF00069 | 0.758 | 
| MOD_N-GLC_2 | 100 | 102 | PF02516 | 0.367 | 
| MOD_PKA_1 | 59 | 65 | PF00069 | 0.661 | 
| MOD_PKA_2 | 28 | 34 | PF00069 | 0.663 | 
| MOD_PKA_2 | 55 | 61 | PF00069 | 0.717 | 
| MOD_Plk_1 | 113 | 119 | PF00069 | 0.647 | 
| MOD_Plk_4 | 113 | 119 | PF00069 | 0.689 | 
| MOD_Plk_4 | 4 | 10 | PF00069 | 0.349 | 
| MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.813 | 
| TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.321 | 
| TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.721 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P382 | Leptomonas seymouri | 35% | 100% | 
| A0A3S5H7Q1 | Leishmania donovani | 84% | 100% | 
| E9AEF5 | Leishmania major | 88% | 100% | 
| E9AHL4 | Leishmania infantum | 84% | 100% | 
| E9AIU5 | Leishmania braziliensis | 72% | 100% |